Trial · NCT03467932
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Cohort A: ORMD-0801 Once Daily - QHS | 69 | |
| Overall Study | STARTED | Cohort A: ORMD-0801 Twice Daily - BID | 68 | |
| Overall Study | STARTED | Cohort A: ORMD-0801 Three Times Daily - TID | 69 | |
| Overall Study | STARTED | Cohort A: Matched Placebo Oral Capsule | 66 | |
| Overall Study | STARTED | Cohort A (Sub-Cohort A): Excipient-Matched Placebo Three Times Daily-TID | 20 | |
| Overall Study | STARTED | Cohort B:ORMD-0801, 8 mg Once Daily - QHS: | 15 | |
| Overall Study | STARTED | Cohort B: ORMD-0801 8 mg Twice Daily - BID | 17 | |
| Overall Study | STARTED | Cohort B: ORMD-0801 16 mg Once Daily - QHS: | 18 | |
| Overall Study | STARTED | Cohort B: ORMD-0801 16 mg Twice Daily - BID | 15 | |
| Overall Study | STARTED | Cohort B - Matched Placebo Oral Capsule | 16 | |
| Overall Study | COMPLETED | Cohort A: ORMD-0801 Once Daily - QHS | 62 | |
| Overall Study | COMPLETED | Cohort A: ORMD-0801 Twice Daily - BID | 58 | |
| Overall Study | COMPLETED | Cohort A: ORMD-0801 Three Times Daily - TID | 58 | |
| Overall Study | COMPLETED | Cohort A: Matched Placebo Oral Capsule | 56 | |
| Overall Study | COMPLETED | Cohort A (Sub-Cohort A): Excipient-Matched Placebo Three Times Daily-TID | 19 | |
| Overall Study | COMPLETED | Cohort B:ORMD-0801, 8 mg Once Daily - QHS: | 13 | |
| Overall Study | COMPLETED | Cohort B: ORMD-0801 8 mg Twice Daily - BID | 15 | |
| Overall Study | COMPLETED | Cohort B: ORMD-0801 16 mg Once Daily - QHS: | 16 | |
| Overall Study | COMPLETED | Cohort B: ORMD-0801 16 mg Twice Daily - BID | 11 | |
| Overall Study | COMPLETED | Cohort B - Matched Placebo Oral Capsule | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03467932/flow